<DOC>
	<DOCNO>NCT01775813</DOCNO>
	<brief_summary>The Health Influences Puberty ( HIP ) Study design explore relationship puberty onset type 2 diabetes adolescent . The result study help u good understand prevent type 2 diabetes youth . Children go many change puberty , include important hormonal behavioral alteration . Among change , long know , puberty , insulin work well puberty . This call physiologic insulin resistance . In healthy child , cause diabetes affect blood sugar way body able compensate making insulin . Indeed , think important part adolescent growth spurt . However , child increase risk develop type 2 diabetes due obesity genetics , worsen insulin resistance puberty compensate youth get diabetes early . The investigator believe type 2 diabetes rarely , ever , see puberty begin , peak diabetes onset adolescent occurs time bad insulin resistance . This specific research project two goal : 1 . To examine effect obesity well body 's insulin work puberty , 2 . To see treatment obese child critical period puberty medication improve insulin resistance ( metformin ) help prevent early onset type 2 diabetes .</brief_summary>
	<brief_title>The Health Influences Puberty ( HIP ) Study</brief_title>
	<detailed_description>Specific Aims : Pediatric insulin resistance related disorder , type 2 diabetes mellitus ( T2DM ) , increase prevalence , portend significant end-organ cardiovascular morbidity mortality . Thus , measure aim understanding cause prevent onset critical . The physiologic decrease insulin sensitivity adolescent puberty well-established . It also know obese adolescent start less insulin sensitive onset puberty lean adolescent , insulin sensitivity worsen puberty progress . While longitudinal cross-sectional data confirm natural recovery pre-pubertal insulin sensitivity normal weight adolescent puberty complete , unknown whether obese adolescent recover pre-pubertal insulin sensitivity . Failure regain pre-pubertal insulin sensitivity end puberty , failure compensatory insulin secretion , may accelerate progression obesity insulin resistance T2DM at-risk youth contribute long-term cardiovascular risk . In addition , obesity insulin resistance associate earlier onset puberty premature adrenarche female . Insulin resistance also contribute gonadal dysfunction polycystic ovarian disease fully pubertal female associate hypogonadism old adult male . Little known effect obesity insulin resistance gonadal function young male . However , persistent metabolic change end puberty may contribute gonadal dysfunction obese youth . Currently , longitudinal study either sex evaluate interaction among obesity , insulin resistance gonadal function puberty . The investigator ' long-term goal well understand metabolic change occur puberty , underlie mechanism , potential contribution adult disease . The overall aim evaluate effect obesity evolution insulin sensitivity gonadal function puberty . In addition , improvement insulin action puberty may slow β-cell deterioration , investigator evaluate whether compensatory insulin secretion also affect obese adolescent whether treatment metformin improve β-cell response . HYPOTHESES : 1 . Obese adolescent show decreased improvement insulin sensitivity Tanner stage 2/3 Tanner 5 compare lean counterpart . 2 . Obese adolescent treat metformin great improvement insulin sensitivity Tanner stage 2/3 Tanner 5 vs. treat placebo . ( See hypothesis schematic ) To test hypothesis , propose address follow Specific Aims : SPECIFIC AIM 1 ( Observational Arm ) : 1 . To compare longitudinal change insulin sensitivity secretion correlate obese normal weight adolescent puberty . 1 . Primary outcome : Change insulin sensitivity ( Si ) , measure frequently sample intravenous glucose tolerance test ( IVGTT ) , early puberty puberty completion obese normal weight adolescent . 2 . Secondary outcome : Change insulin secretion ( AIR ) disposition index ( DI ) measure IVGTT , body composition , fat distribution , marker gonadal function , inflammatory marker time group . SPECIFIC AIM 2 ( Treatment Arm ) : 2 . To compare longitudinal change insulin sensitivity secretion correlate obese adolescent treat metformin placebo puberty . 1 . Primary outcome : Change Si early puberty puberty completion obese control obese adolescent treat metformin . 2 . Secondary outcome : Change AIR DI , body composition , fat distribution , marker gonadal function , inflammatory marker time group .</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>BMI ≥ 95th percentile At least Tanner 2 , Tanner 3 Age ≥ 9 year Absence impair glucose tolerance ( IGT ) , impaired fasting glucose ( IFG ) Type 2 diabetes mellitus ( T2DM ) Presence T2DM , IGT IFG Any disorder medication know effect glucose tolerance ; Hypertension hyperlipidemia require pharmacological intervention ; Weight &gt; 300lbs . due limit image table . Chronic illness</criteria>
	<gender>All</gender>
	<minimum_age>9 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Insulin resistance</keyword>
	<keyword>Puberty</keyword>
	<keyword>Obesity</keyword>
	<keyword>Hypogonadism</keyword>
	<keyword>Gonadal dysfunction</keyword>
	<keyword>Metformin</keyword>
</DOC>